By Priyabrat Biswal
Bhubaneswar, August 10, 2024
A team of researchers has made a groundbreaking discovery on Brahmayoni Hill in Gaya, Bihar, uncovering an array of medicinal plants, with Gymnema sylvestre, commonly known as Gurmar, being one of the most significant findings. This discovery holds immense potential for the future of Ayurvedic medicine, especially in the treatment of diabetes.
Gurmar, a cornerstone in traditional Ayurvedic practices, has gained renewed attention as a critical ingredient in the formulation of BGR-34, an anti-diabetic drug developed by the Council of Scientific and Industrial Research (CSIR). The herb’s unique ability to reduce blood sugar levels is attributed to gymnemic acid, a compound that blocks sugar absorption in the intestine, thereby lowering blood glucose levels. Besides, Gurmar contains flavonoids and saponins, which aid in regulating lipid metabolism, reducing cholesterol, and providing antioxidant benefits.
The discovery was made by a team of researchers from Magadh University, who highlighted their findings in the International Journal of Creative Research Thoughts (IJCRT). They emphasized that Brahmayoni Hill is a treasure trove of natural remedies, with traditional healers relying on its diverse medicinal herbs for centuries. Gurmar stands out for its well-documented anti-diabetic properties, making this discovery particularly relevant in the modern context.
The significance of Gurmar extends beyond its historical uses. In recent years, it has gained recognition as a vital component of BGR-34, an Ayurvedic formulation marketed by Delhi-based Aimil Pharma. BGR-34 combines Gurmar with other potent phyto-ingredients such as Daruharidra, Giloy, Vijaysar, Manjishtha, and Fenugreek to create a comprehensive solution for managing diabetes. The formulation’s effectiveness has been validated by a 2022 study conducted by the All India Institute of Medical Sciences (AIIMS), Delhi, which found that BGR-34 not only reduces blood sugar levels but also aids in weight loss and improves metabolic health.
Commenting on the growing popularity of herbal-based Ayurvedic medicines, Aimil Pharma Executive Director Dr. Sanchit Sharma said, “The surge in lifestyle-related non-communicable diseases has driven increased interest in preventive health, with many turning to natural remedies like BGR-34 for effective management.”
The researchers also drew a parallel between the discovery of Gurmar and the development of Metformin, the first widely used diabetes drug, which was derived from the medicinal plant Galega. They called for further research into Gymnema sylvestre to explore its full therapeutic potential and provide future generations with an effective natural alternative for diabetes management.
Moreover, the study, titled Ethnobotanical Research on Certain Therapeutic Plants Found on Gaya’s Brahmayoni Hill, urged the involvement of local populations in the cultivation of medicinal herbs like Gurmar. By engaging the community in sustainable cultivation practices, researchers believe these valuable medicinal resources can be preserved for future generations, ensuring their availability and continued contribution to healthcare.
This discovery not only highlights the importance of preserving our natural heritage but also underscores the potential of Ayurvedic medicine in addressing modern health challenges. As research continues, the Gurmar herb may well become a cornerstone in the global fight against diabetes, offering a natural, effective, and sustainable solution for millions of people.